What is NDC 44567-400?

44567-400 is the product NDC for Meropenem, Meropenem 500 mg/1 injection, powder, for solution, listed with the FDA by WG Critical Care, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

WG Critical Care, LLC, NDC labeler code 44567. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Meropenem?

42 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Meropenem NDC 44567-400 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)44567-400Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44567-0400Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44567-400-10	4456704001044567040010	10 VIAL in 1 CARTON (44567-400-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (44567-400-01)Marketed from Jan 9, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meropenem
Generic name (nonproprietary): meropenem
Active ingredients: Meropenem — 500 mg/1
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: WG Critical Care, LLCNDC labeler code 44567
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210773
Marketing start: Jan 9, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Carbapenems (Chemical structure)
Identifiers: Product ID 44567-400_544f1665-f5bb-46bd-b6e8-efb61d6b152eSPL ID 544f1665-f5bb-46bd-b6e8-efb61d6b152e
Pharmacologic class: Penem Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N444567040010 followed by a unit qualifier and the quantity

Package 44567-0400-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 44567-400

What is NDC 44567-400?: 44567-400 is the product NDC for Meropenem, Meropenem 500 mg/1 injection, powder, for solution, listed with the FDA by WG Critical Care, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Meropenem.
What is the active ingredient?: Meropenem.
Who is the labeler?: WG Critical Care, LLC, NDC labeler code 44567. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meropenem?: 42 other product NDCs are listed under this name. See all Meropenem NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meropenem NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Meropenem	Meropenem 500 mg/10mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9485	00143-9485-10
Meropenem	Meropenem 1 g/20mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9486	00143-9486-10
Meropenem	Meropenem 500 mg/20mL	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-160	25021-0160-20
Meropenem	Meropenem 1 g/30mL	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-161	25021-0161-30
Meropenem	Meropenem 1 g/20mL	InjectionIntravenous	Civica, Inc.	72572-410	72572-0410-10
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	Civica, Inc.	72572-412	72572-0412-10
Meropenem	Meropenem anhydrous 2 g/1	InjectionIntravenous	Mylan Institutional LLC	72078-081	72078-0081-06
Meropenem	Meropenem anhydrous 2 g/1	InjectionIntravenous	BROOKS STERISCIENCE LIMITED	81962-002	81962-0002-08
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	Qilu Antibiotics Pharmaceutical Co., Ltd.	51810-502	51810-0502-02
Meropenem	Meropenem 1 g/30mL	InjectionIntravenous	Qilu Antibiotics Pharmaceutical Co., Ltd.	51810-503	51810-0503-02

All 43 Meropenem NDCs

Other NDCs under ANDA 210773

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210773
Product	Strength	Form · route	Labeler	Product NDC
Meropenem	Meropenem 500 mg/10mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9485
Meropenem	Meropenem 1 g/20mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9486
Meropenem	Meropenem 500 mg/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-145
Meropenem	Meropenem 1 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-146
Meropenem	Meropenem 1 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-401